{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:06:51Z","timestamp":1791166011549,"version":"4.1.0"},"reference-count":19,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,8,2]]},"DOI":"10.1001\/jama.2022.9165","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T15:34:21Z","timestamp":1659454461000},"page":"425","source":"Crossref","is-referenced-by-count":11,"title":["Cardiovascular Events and Gout Flares"],"prefix":"10.1001","volume":"328","author":[{"given":"Jeffrey L.","family":"Anderson","sequence":"first","affiliation":[{"name":"Intermountain Medical Center, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk U.","family":"Knowlton","sequence":"additional","affiliation":[{"name":"Intermountain Medical Center, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"jed220041r1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in atherosclerosis\u2013no longer a theory.","volume":"67","author":"Libby","year":"2021","journal-title":"Clin Chem"},{"issue":"12","key":"jed220041r2","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"jed220041r3","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction.","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"jed220041r4","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease.","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"jed220041r5","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events.","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"issue":"4","key":"jed220041r6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection.","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"issue":"18","key":"jed220041r7","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/CIRCULATIONAHA.121.057042","article-title":"Influenza vaccination after myocardial infarction.","volume":"144","author":"Fr\u00f6bert","year":"2021","journal-title":"Circulation"},{"issue":"2","key":"jed220041r8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1001\/jamacardio.2016.4494","article-title":"Assessing and refining myocardial infarction risk estimation among patients with human immunodeficiency virus.","volume":"2","author":"Feinstein","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"1","key":"jed220041r9","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","article-title":"Cardiovascular risk in inflammatory arthritis.","volume":"3","author":"Hansildaar","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"8","key":"jed220041r10","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/eurheartj\/ehp567","article-title":"Patients with severe psoriasis are at increased risk of cardiovascular mortality.","volume":"31","author":"Mehta","year":"2010","journal-title":"Eur Heart J"},{"key":"jed220041r11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fmed.2017.00262","article-title":"Novel insights in systemic lupus erythematosus and atherosclerosis.","volume":"4","author":"Teixeira","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"jed220041r12","doi-asserted-by":"publisher","first-page":"2895","DOI":"10.1016\/j.jacc.2020.10.027","article-title":"Inflammatory bowel disease and atherosclerotic cardiovascular disease.","volume":"76","author":"Cainzos-Achirica","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"jed220041r13","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2022.11390","article-title":"Association between gout flare and subsequent cardiovascular events among patients with gout.","author":"Cipolletta","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"jed220041r14","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1038\/s41598-020-63318-8","article-title":"C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1.","volume":"10","author":"Alberts","year":"2020","journal-title":"Sci Rep"},{"key":"jed220041r15","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.amjcard.2004.07.108","article-title":"Elevated C-reactive protein in atrial fibrillation: evidence for an inflammatory pathophysiology.","volume":"94","author":"Anderson","year":"2004","journal-title":"Am J Cardiol"},{"issue":"6","key":"jed220041r16","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a).","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"jed220041r17","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jcmg.2021.11.006","article-title":"Comparison of coronary artery calcium score versus pooled cohort equations score for primary prevention guidance.","volume":"15","author":"Muhlestein","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"jed220041r18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.jcmg.2019.10.019","article-title":"Gout is associated with increased coronary artery calcification and adverse cardiovascular outcomes.","volume":"13","author":"Christensen","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"jed220041r19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1056\/NEJMoa2027892","article-title":"Phase 3 trial of interleukin-1 trap rilonacept in recurrent pericarditis.","volume":"384","author":"Klein","year":"2021","journal-title":"N Engl J Med"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2794785\/jama_anderson_2022_ed_220041_1659390428.90086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T11:04:02Z","timestamp":1676286242000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2794785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,8,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.9165","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,2]]}}}